First Time Loading...

Reata Pharmaceuticals Inc
NASDAQ:RETA

Watchlist Manager
Reata Pharmaceuticals Inc Logo
Reata Pharmaceuticals Inc
NASDAQ:RETA
Watchlist
Price: 172.36 USD Market Closed
Updated: May 1, 2024

Reata Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Reata Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Reata Pharmaceuticals Inc
NASDAQ:RETA
Cash from Financing Activities
$90.6m
CAGR 3-Years
-51%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$15.8B
CAGR 3-Years
-32%
CAGR 5-Years
3%
CAGR 10-Years
-7%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
-$9.4B
CAGR 3-Years
-101%
CAGR 5-Years
-22%
CAGR 10-Years
-24%
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$4.8B
CAGR 3-Years
-19%
CAGR 5-Years
18%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$3.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Reata Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
90.6m USD

Based on the financial report for Jun 30, 2023, Reata Pharmaceuticals Inc's Cash from Financing Activities amounts to 90.6m USD.

What is Reata Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-12%

Over the last year, the Cash from Financing Activities growth was 7 190%. The average annual Cash from Financing Activities growth rates for Reata Pharmaceuticals Inc have been -51% over the past three years , -12% over the past five years .